Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reversible posterior leukoencephalopathy syndrome induced by sunitinib.

× No keyword cloud information.

26 in total

1. Reversible posterior leukoencephalopathy syndrome and trastuzumab.

Authors: Hiroyasu Kaneda; Isamu Okamoto; Taroh Satoh; Kazuhiko Nakagawa
Journal: Invest New Drugs Date: 2011-06-03 Impact factor: 3.850

Review 2. Neurotoxicity of biologically targeted agents in pediatric cancer trials.

Authors: Elizabeth M Wells; Amulya A Nageswara Rao; Joseph Scafidi; Roger J Packer
Journal: Pediatr Neurol Date: 2012-04 Impact factor: 3.372

Review 3. [Neurological complications of neurooncological therapy].

Authors: U Herrlinger; J P Steinbach
Journal: Nervenarzt Date: 2010-08 Impact factor: 1.214

4. Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy.

Authors: Stephanie H Hernandez; Sage W Wiener; Silas W Smith
Journal: J Med Toxicol Date: 2010-06

5. Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen.

Authors: Franck Bürki; Kattalin Badie; Philippe Bartoli; Pascale Bernard; Jean Louis Montastruc; Haleh Bagheri
Journal: Br J Clin Pharmacol Date: 2008-02-15 Impact factor: 4.335

6. Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer.

Authors: Christina A K Kim; Julie Price-Hiller; Quincy S Chu; Keith Tankel; Ron Hennig; Michael B Sawyer; Jennifer L Spratlin
Journal: Invest New Drugs Date: 2014-05-23 Impact factor: 3.850

7. Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma.

Authors: Erkan Dogan; Sercan Aksoy; Cagatay Arslan; Didem S Dede; Kadri Altundag
Journal: Med Oncol Date: 2010-12 Impact factor: 3.064

Review 8. Adverse effects of anticancer agents that target the VEGF pathway.

Authors: Helen X Chen; Jessica N Cleck
Journal: Nat Rev Clin Oncol Date: 2009-07-07 Impact factor: 66.675

Review 9. Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors: Rashmi R Shah
Journal: Drug Saf Date: 2017-05 Impact factor: 5.606

10. Management of side effects associated with sunitinib therapy for patients with renal cell carcinoma.

Authors: Anita Schwandt; Laura S Wood; Brian Rini; Robert Dreicer
Journal: Onco Targets Ther Date: 2009-02-18 Impact factor: 4.147